Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-lapse notice (and its prior Revision: v3.4.1). No core study content, eligibility criteria, or results were modified.SummaryDifference0.3%

- Check20 days agoChange DetectedAdded a government funding notice detailing operational status of the NIH Clinical Center and updated the site to revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC-related metadata (Revision: v3.4.0; Last Update Submitted that Met QC Criteria). Removed or renamed the previous QC label and version (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedA consolidated 'Locations' section lists all participating sites by state, replacing the previous per-state location sections. The HHS Vulnerability Disclosure link was removed and the page updated to Revision: v3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of Revision: v3.2.0. This appears to be a backend/UI update without changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.